期刊文献+

多沙唑嗪对于改善输尿管支架管引起的下尿路症状的作用 被引量:7

The effect of doxazosin in improving symptoms and quality of life for patients with indwelt double-J ureteral stents
下载PDF
导出
摘要 目的评价多沙唑嗪对置入输尿管支架管(D-J)患者下尿路症状以及生活质量的改善作用。方法从2010年3月至2010年12月,共收集了28例输尿管镜碎石后留置D-J管的患者入组本研究。患者被随机分为2组(治疗组、对照组),对照组14例患者未接受多沙唑嗪治疗,治疗组14例患者接受了2~4周的多沙唑嗪(4mg/d)治疗。所有患者均在2~4周后D-J管去除之前接受国际前列腺症状评分和世界卫生组织生存质量测定量表简表对患者下尿路症状及生存质量进行评估。结果对照组IPSS平均分为9.79,治疗组中IPSS平均分为5.07,P<0.05;对照组中生理领域平均分为13.80,治疗组中为15.43,P<0.05。结论多沙唑嗪可改善一系列D-J管相关下尿路症状以及患者的生活质量。 Objective To evaluate the effect of doxazosin in improving symptoms and quality of life for patients with indwelt double-J ureteral stents.Methods Between March 2010 to Sept.2010,a total of 28 patients with indwelt double-J ureteral stents after ureteroscopic stone removal were enrolled in this study.Patients were prospectively randomized into two groups.14 patients in Group 1 didn't receive doxazosin therapy.Another 14 patients in Group 2 received doxazosin(4 mg/day) for 2 to 4 weeks.All patients completed the International Prostate Symptom Scale(IPSS) and the brief version of the World Health Organization Quality of Life Instrument for evaluating lower urinary tract symptoms and quality of life before double-J stent removal 2 to 4 weeks later.Results The mean score of IPSS was 9.79 in Group 1 and 5.07 in Group 2,P0.05;the mean score of physical domain was 13.80 in Group 1 and 15.43 in Group 2,P0.05.Conclusions Doxazosin improved a subset of stent-related lower urinary tract symptoms and quality of life.
出处 《现代泌尿外科杂志》 CAS 2012年第1期46-48,共3页 Journal of Modern Urology
基金 上海市普陀区人民医院院级项目(No.RYK09Q-03)
关键词 多沙唑嗪 D-J管 生活质量 药物治疗 输尿管结石 doxazosin double-J stent quality of life drug therapy ureterolithiasis
  • 相关文献

参考文献8

  • 1CHEW BH, KNUDSEN BE, DENSTEDT JD.The use of stents in contemporary urology[J]. Curr Opin Urol, 2004, 14(2):111-115.
  • 2DYER RB, CHEN MY, ZAGORIA RJ, et al. Complications of ureteral stent placement[J]. Radiographics, 2002, 22(5):1005-1022.
  • 3JOSHI HB, STAINTHROPE A, KEELEY FX, et al. Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis[J]. J Endourol,2001, 15(2):151-154.
  • 4DELIVELIOTIS C, CHRISOFOS M, OUGOUSIS E. Is there a role for alpha1-blockers in treating double-J stent-related symptoms?[J]. Urology, 2006, 67(1): 35-39.
  • 5XUE Z, ZHANG Y, DING Q, et al. Doxazosin gastrointestinal therapeutic system versus tamsulosin for the treatment of benign prostatic hyperplasia: a study in Chinese patients[J]. Int J Urol, 2007, 14(2):118-122.
  • 6KAPLAN SA, OLSSON CA, TE AE. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of follow-up does it work[J].J Urol,1996, 155(6):1971-1974.
  • 7JUDE UO, ABDEL WA. The reliability and validity of the short version of the WHO quality of life instrument on Arab general population[J]. Ann Saudi Med,2009,29(2):98-104.
  • 8CHI WC, JUNG DW, GRACE Y, et al. Agreement between the WHOQOL-BREF Chinese and Taiwan Residents versions in the elderly[J]. J Formos Med Assoc,2009, 108(2):164-169.

同被引文献39

  • 1孙少鹏,商学军.舍曲林联合多沙唑嗪控释片治疗早泄的临床观察[J].中华男科学杂志,2005,11(3):231-232. 被引量:18
  • 2那彦群,叶章群,孙光,等.中国泌尿外科疾病诊断治疗指南[M].人民卫生出版社,2011:30.
  • 3CHEW BH, KNUDSEN BE, DENSTEDT JD.The use of stents in contemporary urology[J]. Curr Opin Urol,2004,14(2):111-115.
  • 4〖ZK(#〗ECKE TH, BARTEL P, HALLMANN S,et al. Evaluation of symptoms and patients comfort for JJ-ureteral stents with and without antireflux-membrane valve.[J]. Urology,2010,75(1):212-216.
  • 5DELLIS AE,KEELEY FX JR,MANOLAS VI, et al.Role of α-blockers in the treatment of stent-related symptoms: a prospective randomized control study[J]. Urol,2014,83(1):56-61..
  • 6KANOFSKY JK,NITTI VW.Tolterodine for treatement of overactive bladder[J].Urol Clin North Am,2006,33(4):447-453.
  • 7LAMB AD, VOWLER SL, JOHNSTON R, et al. Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort. [J].BJU Int,2011,108(11):1894-1902. .
  • 8YAKOUBI R, LEMDANI M, MONGA M, et al.Is there a role for α-blockers in ureteral stent related symptoms? A systematic review and meta-analysis[J]. J Urol,2011,186(3):928-934.
  • 9DAVENPORT K, KUMAR V, COLLINS J, et al. New ureteral stent design does not improve patient quality of life: a randomized, controlled trial[J]. J Urol,2011,185(1):175-178.
  • 10KAPLAN SA,OLSSON CA,TE AE. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of follow-up does it work?[J].J Urol,1996,155(6):1971-1974.

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部